PPH Top Holdings & Constituents
PPH, offered by VanEck, holds 26 reported positions across $944.9M in assets. Its largest holdings are Eli Lilly & Co (LLY) (18.70%), Novartis AG (NVS) (10.76%), and Merck & Co Inc (MRK) (9.68%). The 5 biggest positions account for 49.18% of reported assets. The table below lists every reported holding with its portfolio weight and market value in US dollars — open any constituent to research its own performance.
| Position | Weight | Market Value |
|---|---|---|
LLY Eli Lilly & Co | 18.70% | $240.48M |
NVS Novartis AG | 10.76% | $138.39M |
MRK Merck & Co Inc | 9.68% | $124.48M |
PFE Pfizer Inc | 5.23% | $67.22M |
NVO Novo Nordisk A/S | 4.81% | $61.85M |
Holdings data comes from the latest SEC Form N-PORT-P filing for this fund, covering the reporting period ended Mar 31, 2026. Market values are reported in US dollars, and each weight represents the position's share of reported fund assets. Cash, derivatives, and rounding can mean displayed weights do not total 100%. Funds rebalance and file on a schedule, so this page may not reflect intraday or post-filing changes.